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Abstract
The N-hydroxylating flavoprotein monooxygenases are siderophore biosynthetic enzymes that
catalyze the hydroxylation of the sidechain amino-group of ornithine or lysine or the primary
amino-group of putrescine. This hydroxylated product is subsequently formylated or acylated and
incorporated into the siderophore. Importantly, the modified amino-group is a hydroxamate and
serves as an iron chelating moiety in the siderophore. This review describes recent work to
characterize the ornithine hydroxylases from Pseudomonas aeruginosa (PvdA) and Aspergillus
fumigatus (SidA) and the lysine hydroxylase from Escherichia coli (IucD). This includes
summaries of steady and transient state kinetic data for all three enzymes and the X-ray
crystallographic structure of PvdA.
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1. Introduction
Since iron serves as a cofactor in enzymes that catalyze essential biological reactions,
bacteria, fungi and plants have developed several mechanisms for scavenging iron from their
environments [1, 2]. One such mechanism is the production and secretion of low molecular
weight iron chelators called siderophores, followed by the import of the iron-loaded form [3,
4]. Some species of bacteria and fungi generate hydroxamate siderophores, which are
associated with pathogen virulence [5–7] and are derived from amino acids and other
metabolic intermediates [8–10], with the iron chelating moiety derived from a hydroxylated
and formylated or acylated lysine, ornithine or putrescine. The enzymes that hydroxylate the
primary amino-group of the sidechain belong a group of functionally-related enzymes called
the N-hydroxylating flavoprotein monooxygenases (NMO). NMOs are part of the class B
flavoprotein monooxygenases, which also contains the flavin-containing monooxygneases
(FMOs) and Baeyer Villiger monooxygenase (BVMOs) [11]. The focus of this review is on
the recent advances in the study of the NMO enzymes.
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2. Study of NMOs hampered by the inability to produce soluble enzyme for
experimentation
The most studied of the N-hydroxylating flavoprotein monooxygenase proteins are the
ornithine hydroxylases from Pseudomonas aeruginosa (PvdA) and Aspergillus fumigatus
(SidA) and the lysine hydroxylase from Escherichia coli (IucD). All three have been
produced as soluble, recombinant proteins and purified for steady state and/or transient state
analyses. PvdA has been produced with an N-terminal histidine tag [12–14]. Other
researchers had difficulty producing a soluble form of PvdA; however, this may be due to
problems with mutations introduced by cloning. The original sequence reported for PvdA
[15] is inconsistent with that from the Pseudomonas aeruginosa PAO1 sequencing project
[16]. The inconsistent sequence is due to a deletion of a single adenine nucleotide at position
1242 that resulted in a frameshift at amino acid 385. The resulting protein has 41 incorrect
C-terminal amino acids followed by a premature stop (426 amino acids total, not 443). This
construct appears to have been used to promote the idea that PvdA is a membrane associated
protein in later work (clones producing full-length and deletions of a 426 amino acid
protein), although this is unclear as the sequence alignment published in the same article
uses the correct sequence (443 amino acids) [17]. The production of SidA, the fungal
ornithine hydroxylase, also met with solubility problems. SidA has been produced with an
N-terminal histidine tag [18] or as an maltose binding protein fusion [19].
Several truncation mutants were generated of IucD, a bacterial lysine hydroxylase, to
produce a soluble form of this enzyme [7]. The final result was a form of the enzyme with
the first 48 amino acids replaced with an N-terminal segment of β-galactosidase. These data
were also used to substantiate the idea that IucD is generally membrane associated [20],
most likely through the N-terminus [21]. However, active enzyme was purified from E. coli
strain EN222 (not recombinant protein) [22] and also with an N-terminal histidine tag [23].
As we will see in the discussion of the structure of PvdA later, the IucD-βGal fusion
removes a significant portion of the FAD binding motif, and therefore will not be used
herein for discussion of mechanism.
3. Oligomerization and FAD binding of purified enzymes
Two interesting differences are noted upon purification of these three enzymes. First, they
are reported to have differing oligomeric states: PvdA is observed to be monomeric in
solution [14], SidA is reported to be dimeric [18] or tetrameric [19], and the βGal-IucD
fusion is active as a tetramer at high salt but the removal of salt led to an inactive monomer
[24]. Finally, PvdA [12, 14] and recombinant IucD [24, 25] purified without flavin and do
not bind flavin tightly, whereas ~60% of SidA has FAD bound following purification [18,
19].
4. Steady state analyses of PvdA, SidA and IucD
Steady state analyses of PvdA, SidA and IucD have produced results that are consistent
among the three. The enzymes are FAD-dependent: FMN was tested for PvdA and found to
be insufficient as a flavin co-factor [12, 14], and IucD purified from E. coli strain EN222
(not recombinant protein) had FAD bound [22]. PvdA [12, 14] and SidA [19] are specific
for NADPH. NADH does not serve as an efficient electron donor. PvdA [12, 14], SidA [19]
and IucD [25] were found to be highly specific for their substrates. In terms of
hydroxylation, PvdA [14] and SidA [19] are specific for ornithine, whereas lysine is a non-
substrate effector that promotes NADPH oxidase activity without subsequent N-
hydroxylation. Putrescine, among other analogues, shows no activity by either the NADPH
oxidation or N-hydroxylation assay [14]. IucD is specific for lysine, showed no catalytic
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activity for ornithine, and homolysine was a non-substrate effector [25]. Steady state
experiments also provided the first mechanistic information for these proteins. First, FAD
reduction is substrate independent (PvdA [14], SidA [19]). Second, a long lived flavin-
intermediate is observed without substrate (PvdA [14] and SidA [19]). Finally, NADP+
remains bound throughout the oxidative half reaction (PvdA [26] and SidA [18, 19]).
5. Kinetic mechanism as determined by transient kinetic analyses of PvdA
and SidA
Transient kinetic analyses of PvdA [14] and SidA [18] have provided similar reaction
mechanisms for the two enzymes with only one difference, and can be considered the basis
for all of this class (Figure 1). Substrate is not required for the reduction of flavin by
NADPH, nor does it accelerate the process [13, 18]. The reduction of the flavin is observed
as a decrease in absorbance at 450 nm [13, 18]. The biphasic nature of the reduction curves
has been attributed to reduction and NADP+ release [13] or to binding and reduction [18],
with the latter correct in light of the more recent observations that NADP+ remains bound
throughout the oxidative half reaction as cited in the previous section. After NADPH binds
and reduces the flavin, oxygen binds and adds to the C4a-position of the flavin forming a
long-lived flavin intermediate. For PvdA, this intermediate is hypothesized to be a
peroxyflavin (absorbs at ~360), which is converted to a hydroperoxyflavin (~380 nm) by
donation of a proton from the substrate amino-group [13]. The evidence for this comes from
very early timepoints at which a spectral shift from 361 to 376 nm is observed [13], as seen
previously for cyclohexanone monooxygenase [27]. For SidA, the long-lived intermediate is
proposed to be the hydroperoxyflavin (~380 nm) and stabilized by the presence of NADP+
with no initial peroxyflavin intermediate observed [18]. The rate of the formation of the
intermediate is enhanced by the addition of substrate, 80-fold for PvdA [13] and 5-fold for
SidA [18]. The hydroperoxyflavin is the reactive intermediate, which donates the distal
oxygen to the substrate thereby forming hydroxyornithine and the hydroxyflavin
intermediate (increase in absorbance at both 390 nm [13, 18]). The hydroxyflavin
intermediate dehydrates to regenerate the oxidized flavin (decrease in absorbance at 390 nm
[13] and increase in 450 nm [13, 18]). The hydroxyornithine and NADP+ dissociate and the
cycle continues.
6. Structure determination of PvdA
The first structure of an N-hydroxylating flavoprotein monooxygenase was determined by
seleno-methionine multiwavelength anomalous dispersion to 1.9 Å [26]. The structure
revealed a three domain enzyme with an FAD binding domain comprising residues 1 – 171,
356 – 396 and 405 – 443 (blue in Figure 2A). The NADPH binding domain is inserted into a
loop of the FAD binding domain and includes residues 170 – 245 and 285 – 355 (red in
Figure 2A). Both of these domains are characteristic /β Rossman-like nucleotide binding
folds. The third domain is a substrate binding domain composed of residues 248–285 and
398 – 404 (yellow in Figure 2A). This smallest domain is helical in nature. This structure,
along with the 3.03 Å reduced structure published in the same article [26], have FAD(H2),
NADP(H) and (hydroxy)ornithine bound in the active site (sticks in Figure 2).
6.1. FAD binding
Considerable speculation on the structural composition of this class of enzymes, especially
related to substrate and coenzyme binding motifs, predated the completion of the PvdA
structure. Sequence analysis led to the proposal that the FAD binding motif was GXGXXP
(residues 15 – 20 in PvdA, Figure 3) [28]. Due to the previously mentioned difficulty in
expression both PvdA and IucD in a soluble form, it was hypothesized that the N-terminal
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region of these proteins constituted a membrane binding region, but the overlap with the
FAD binding sequence led to some debate about the assignment of substrate, co-substrate
and FAD binding motifs [21, 29]. Admittedly, by hydropathy plot the region (residues 10–
30) is quite hydrophobic and appears to be transmembrane, leading the authors to suggest
that the “N-terminal hydrophobic domain interacts with the lipid bilayer by forming a U-
shaped or re-entrant loop aided by contiguous G19–P20 residues without actually crossing
the membrane” [30]. The structure of PvdA [26] allows for the assignment of the FAD
binding motif as two amino acids C-terminal to that proposed: 17GXGXXN22 (Figure 2B).
Furthermore, the structure clearly shows that the residues of the putative membrane binding
motif form the first strand and helix of the classical βαβ dinucleotide binding motif involved
in binding of the ribose and phosphates of the FAD [26].
As noted previously, PvdA and IucD bind FAD weakly, whereas SidA can be purified with
FAD bound. Comparing the structure of PvdA to the available structures for flavin-
containing monooxygenases and Baeyer Villiger monooxygeanses led to the proposal that
PvdA may not bind FAD as tightly because the FAD binding cleft is much shallower in
PvdA [26]. Indeed, most of the FAD is solvent exposed in PvdA, whereas in FMOs and
BVMOs, the FAD is buried and solvent inaccessible [31–35]. An exception is
phenylacetone monooxygenase, a BVMO that also does not bind FAD stably, and indeed
has the adenine moiety of the FAD exposed to solvent [36]. Based on the sequence
alignment in Figure 3, we propose that IucD, which is smaller than PvdA by 46 amino acids,
will have a similarly open FAD binding site. On the other hand, SidA is 45 residues longer
than PvdA with insertions in loops and strands. An initial hypothesis is that the additional
residues are at least partially responsible for shielding the FAD from competing solvent
interactions when bound to SidA, promoting more stable FAD binding and less uncoupling
of NADPH oxidiation and product formation. However, this hypothesis seems unlikely since
the insertions are not in close proximity to the FAD (grey sections of structure highlighted
by orange arrows in Figure 2A).
6.2. NADPH binding
NADPH binding has been hypothesized to be a function of the consensus sequence GGG(Q/
N)S(G/A) [28]. Indeed, in PvdA, these residues (214–219) form a turn between the first
strand and helix of the dinucleotide binding βαβ motif analogous to the GXGXXN for FAD
binding (Figure 2C) [26]. The glutamine hydrogen bonds with the backbone of Asp289
thereby stabilizing the loop conformation, and the serine hydrogen bonds with the phosphate
of the NADPH molecule. The co-substrate specificity (NADPH instead of NADH) is
conferred by two residues: Arg240 and Ser286. These two residues form hydrogen bonds to
the phosphate of the adenine ribose of the NADPH, which is not present in NADH. The
arginine is conserved in both SidA (Arg276) and IucD (Arg216), whereas the serine is only
conserved in SidA (Ser322 in SidA, Gly262 in IucD; Figure 3).
6.3. Substrate binding
Sequence alignment of the N-hydroxylating monooxygenases led to the proposal that the
‘FATGY’ motif (residues 351–355 in PvdA) is involved in substrate binding [28]. The
structure of PvdA reveals this sequence to be located in a loop which forms part of the
NADPH binding pocket [26]. The substrate binding domain is instead composed of a three
helix insertion within the NADPH binding domain and one helix derived from the C-
terminal portion of the FAD binding domain (Figure 2A). The ornithine is stabilized in the
structure by five residues: Gln64, Lys69, Asn254, Thr283 and Asn284 (Figure 2C). Whereas
Gln64 and Asn284 align the N5-amino-group for hydroxylation, Lys69, Asn254, and the
backbone carbonyl of Thr283 stabilize the ornithine backbone amine and carboxylate,
conferring substrate and stereochemical specificity. As seen in Figure 3, these residues are
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conserved in both SidA and IucD, with the exception of Asn284 (Ser260 in IucD) and
Asn254 (Asp230 in IucD), which are conservative changes that would provide similar
hydrogen binding capabilities. In the case of Ser260 of IucD, this might be an artifact of the
sequence alignment, and the corresponding residue at that position may be Asp261.
7. Other NMOs identified to date
The siderophores into which the products of catalysis are incorporated are shown for PvdA
(pyoverdin), SidA (ferricronin) and IucD (aerobactin) in Figure 4. At least nine other
ornithine hydroxylases have been identified, all involved in siderophore production (Table
1). Along with IucD, at least one other lysine hydroxylase has been identified, with
mycobactin assembly being unusual. The accepted norm is that the ornithine or lysine
sidechain is hydroxylated as a first step in biosynthesis of the siderophore, followed by
formyl- or acylation and finally incorporation into the siderophore [15, 37–39]. The MtbG
enzyme from Mycobacterium tuberculosis appears to be a tailoring enzyme, hydroxylating
the previously incorporated and acylated sidechain amino-group as a last step in siderophore
biosynthesis [40, 41]. Finally, a putrescine (or 1,4-diaminobutane) hydroxylase has been
identified from Bordetella sp siderophore production [42, 43].
8. Future work
The mechanism of catalysis for the N-hydroxylating monooxygenases has begun to be
elucidated and the first structure has been reported for this functionally-related class of
enzymes. While the controversy over membrane-binding seems to be decided in favor of
these being soluble enzymes, new questions arise for further investigation. For example,
further transient kinetic work is required to validate the presence of a peroxyflavin
intermediate and continued crystallographic work may identify structural determinants of
flavin-intermediate stabilization.
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N-hydroxylating flavoprotein monooxygenases in hydroxamate siderophore
biosynthesis
Review of kinetic studies revealing mechanism
Review of structural studies revealing FAD, NADPH and substrate binding/
specificity
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Kinetic mechanism for N-hydroxylating flavoprotein monooxygenases based on data for
PvdA [13, 14, 26] and SidA [18, 19].
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Structure of the ornithine hydroxylase from Pseudomonas aeruginosa, PvdA. A) Cartoon of
the oxidized structure of PvdA (PDB code 3S5W) [26]. The FAD binding domain is shown
in blue, the NADPH binding domain in red and the ornithine binding domain in yellow. The
FAD is yellow sticks, the NADP+ is blue sticks, and the ornithine is green sticks. The grey
elements of secondary structure and loops regions represent areas of sequence insertion for
SidA and are highlighted with orange arrows. B) Stereo image of the FAD binding site and
C) Stereo image of the NADP+ binding site. In parts B and C, the cartoon is colored by
secondary structure with α-helices red, β-strands yellow and loop regions green. D) Stereo
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image of the ornithine binding site. Here the cartoon is colored as in part A. Hydrogen
bonding and salt links are shown as dashed lines.
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Sequence alignment for SidA, PvdA, and IucD. Secondary structure elements of PvdA
shown above the sequences as arrows (β-strands) and cylinders (α-helices) [26]. Blue
elements are found in the FAD binding domain, red in the NADPH binding domain and
yellow in the ornithine binding domain. Residues colored blue are involved in FAD binding,
red in NADPH binding and yellow in ornithine binding. The blue box represents the region
of the protein previously predicted to be both involved in FAD and membrane binding [21,
30]. The green box highlights the ‘FATGY’ sequence hypothesized to be involved in
substrate binding [21]. The numbers above the sequences correspond to the amino acid
numbers for PvdA. Primary sequence alignments indicate an overall identity of ~15% and
46% similarity among the three enzymes. There is a 40% identity (73% similarity) between
PvdA and SidA, the two ornithine hydroxylases [44]. Each ornithine hydroxylase shares
similar percentages when compared to IucD, the lysine hydroxylase, with 25% identity
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(59% similarity) between PvdA and IucD, and 20% identity (53% similarity) between IucD
and SidA.
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Examples of hydroxamate siderophores that include products of the N-hydroxylating
flavoprotein monooxygenases. Pyoverdin is the siderophore produced with the assistance of
PvdA. Ferrocronin production involves SidA, aerobactin production requires IucD, and
alcaligin requires AlcA catalysis. The portion of the compound that is derived from
ornithine, lysine or putrescine is shown in bold.
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Table 1
N-hydroxylating flavoprotein monooxygenases.
Substrate Enzyme Organism Siderophore Reference
Lysine
IucD Escherichia coli aerobactin [7, 21–25, 28, 29, 45–47]
N-acyl-lysine
MbtG Mycobacterium tuberculosis mycobactin [40, 41]
Ornithine
CchB Streptomyces coelicolor coelichelin [48]
OMO1 Magnaporthe grisea coprogen, ferricrocin [49, 50]
OMO1 Omphalotus alearius ferrichrome [51]
OrnOH Aureobasidium pullulans fusigen [52]
PsbA Pseudomonas aeruginosa pseudobactin [53]
PvdA Pseudomonas aeruginosa pyoverdin [12–15, 17, 30, 54]
PvdA Burkholderia cepacia ornibactin [55]
Sid1 Ustilago maydis ferrichrome [56]
SidA Aspergillus fumigatus fusarinine, ferricronin [6, 18, 19, 39]
SidA Aspergillus nidulans fusarinine, ferricronin [57]
VbsO Rhizobium leguminosarum vicibactin [58]
Putrescine
AlcA Bordetella bronchiseptica alcaligin [42]
AlcA Bordetella pertussis alcaligin [43]
Bioorg Chem. Author manuscript; available in PMC 2012 December 1.
